Patent · US Active

Compositions comprising aticaprant

US12201610B2 · kind B2 · utility

0Cited by

19References

19Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Nicolaas Martha Felix Goyvaerts · Beerse, BE
Mark Schmidt · Ekeren, BE
Vanina Popova · Nijlen, BE
Adam Savitz · Greenwich, US
Rama Melkote · Jalan Pedongkelan, US
Wayne C. Drevets · Titusville, US
Srihari Gopal · Montgomery, US
Darrel Pemberton · Zwaneven, BE
Chakradhar Lagishetty · King of Prussia, US
Iva Kezic · Ekeren, BE
Mahesh N. Samtani · Flemington, US
Tom Huybrechts · Merelbeke, BE
Geert Van der Avoort · Retie, BE
Matthieu Ravelingien · Geel, BE
Laura Martinez Marcos · Ekeren, BE
Tatiana Marcozzi · Ekeren, BE
Katarina Jokicevic · Mortsel, BE

Key dates

Filing date	Mar 27, 2024
Grant date	Jan 21, 2025
Priority date	—
Expiry date	Mar 27, 2044

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/24
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to compositions, including oral compositions in the form of tablets, comprising aticaprant and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.